Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
Am J Respir Crit Care Med
.
2019 May 15;199(10):1175-1176.
doi: 10.1164/rccm.201811-2138ED.
Authors
Jun-Chieh J Tsay
1
,
Leopoldo N Segal
1
Affiliation
1
1 Division of Pulmonary and Critical Care Medicine New York University School of Medicine New York, New York.
PMID:
30485116
PMCID:
PMC6519852
DOI:
10.1164/rccm.201811-2138ED
No abstract available
Publication types
Comment
MeSH terms
Biomarkers
Hospitalization
Humans
Microbiota*
Pulmonary Disease, Chronic Obstructive*
Sputum
Substances
Biomarkers
Grants and funding
R01 HL125816/HL/NHLBI NIH HHS/United States
R37 CA244775/CA/NCI NIH HHS/United States